Key Points
- Oscar Health CEO Mark Bertolini acquired 1,000,000 shares on April 6 at an average price of $11.92 (total ≈ $11.92M), raising his stake to 10,196,876 shares — a 10.87% increase — disclosed in an SEC filing.
- Recent quarter: Oscar reported ($1.24) EPS versus consensus ($0.92) and revenue of $2.81B vs $3.12B expected, with revenue up 17.3% YoY but negative net margin and return on equity.
- Market and analyst view: OSCR trades near $12.96 (12‑month range $10.69–$23.80) with a $3.86B market cap and a consensus "Hold" rating and average price target of $16.88.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CEO Mark Bertolini acquired 1,000,000 shares of the stock in a transaction that occurred on Monday, April 6th. The stock was purchased at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the transaction, the chief executive officer owned 10,196,876 shares in the company, valued at $121,546,761.92. This represents a 10.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Oscar Health Price Performance
OSCR opened at $12.96 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $23.80. The company has a fifty day simple moving average of $13.12 and a 200 day simple moving average of $15.73. The stock has a market cap of $3.86 billion, a P/E ratio of -7.45 and a beta of 1.93.
Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by ($0.32). The firm had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.Oscar Health's revenue for the quarter was up 17.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.62) EPS. On average, research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on OSCR shares. Wall Street Zen upgraded Oscar Health from a "sell" rating to a "hold" rating in a report on Saturday, February 14th. Barclays set a $18.00 target price on Oscar Health and gave the stock an "equal weight" rating in a report on Monday, January 5th. Weiss Ratings reiterated a "sell (d)" rating on shares of Oscar Health in a report on Thursday, January 22nd. UBS Group reiterated a "neutral" rating and set a $15.00 target price on shares of Oscar Health in a report on Wednesday, February 11th. Finally, Raymond James Financial upgraded Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 target price for the company in a report on Thursday, February 12th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $16.88.
Check Out Our Latest Stock Analysis on OSCR
Hedge Funds Weigh In On Oscar Health
Hedge funds have recently modified their holdings of the stock. Udine Wealth Management Inc. grew its holdings in shares of Oscar Health by 138.4% in the 3rd quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company's stock valued at $2,774,000 after acquiring an additional 85,083 shares in the last quarter. Q Fund Management Hong Kong Ltd bought a new position in shares of Oscar Health in the 3rd quarter valued at about $5,940,000. State of Michigan Retirement System bought a new position in shares of Oscar Health in the 3rd quarter valued at about $27,448,000. Halter Ferguson Financial Inc. grew its holdings in shares of Oscar Health by 81.7% in the 3rd quarter. Halter Ferguson Financial Inc. now owns 385,315 shares of the company's stock valued at $7,294,000 after acquiring an additional 173,249 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Oscar Health by 2.1% in the 3rd quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock valued at $381,636,000 after acquiring an additional 423,184 shares in the last quarter. Institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
